Three cardiometabolic-related news items have been observed: MiniMed has registered a new study of its next-gen extended-wear CGM, called Unity (view CT.gov record); FDA accepted Bayer’s sNDA for finerenone in non-T2DM CKD (view press release); and Suzhou Ribo Life Science submitted a Ph1 CTA in the EU for its INHBE siRNA in obesity (view press release). Below, FENIX provides highlights and insights for the respective news items.